Cannabis and multiple sclerosis.

Expert Review of Neurotherapeutics
Yara Dadalti FragosoMiguel Angel Macias

Abstract

Patients with multiple sclerosis (MS) may suffer from spasticity and pain during their disease course. Baclofen, dantrolene, diazepam and gabapentin have been used as first-line options to treat these conditions, with modest results. Medical use of marijuana smoking has bypassed traditional clinical trials and has been legalized as a therapeutic option for MS-related spasticity and pain in some countries. Cannabis-derived drugs have been tested and approved for medical use. With the development of nabiximols by the pharmaceutical industry, more countries have made it possible for patients with MS to have legal access to cannabis-related therapies. The evidence-based data on nabiximols and MS-related spasticity, pain, and urinary symptoms is consistent. There are over 7,500 patients reported in 33 studies (12 from the United Kingdom and 11 from Italy). Nabiximols is safe and effective for patients with MS whose spasticity could not be treated with the first-line oral drugs. At present, legislation, bureaucracy and costs involved in prescribing this drug limit the experience of neurologists from many countries. There is no scientific evidence that smoking marijuana can be beneficial to patients with MS.

References

Jan 1, 1987·Advances in Alcohol & Substance Abuse·J T UngerleiderL W Myers
Mar 1, 1994·Clinical Pharmacology and Therapeutics·H S GreenbergE F Domino
Mar 22, 2003·Clinical Pharmacokinetics·Franjo Grotenhermen
Jun 9, 2004·Neurology·A J ClarkM E Lynch
Aug 26, 2004·Multiple Sclerosis : Clinical and Laboratory Research·C M BradyC J Fowler
Nov 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·J P ZajicekA J Thompson
Mar 23, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·R M FreemanJ Zajicek
Nov 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·D T WadeP Robson
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C CollinUNKNOWN Sativex Spasticity in MS Study Group
Dec 22, 2007·Expert Opinion on Investigational Drugs·Mellar P Davis
Apr 2, 2009·Journal of Endocrinological Investigation·F FalloN Sonino
Sep 11, 2010·Multiple Sclerosis : Clinical and Laboratory Research·R B C KaviaC J Fowler
Feb 16, 2011·Journal of Addiction Medicine·Rebecca D CreanBarbara J Mason
Mar 3, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A NovotnaUNKNOWN Sativex Spasticity Study Group
Dec 2, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Peter A ClarkCameron Fick
Apr 25, 2012·Expert Review of Neurotherapeutics·Derick Wade
May 16, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jody Corey-BloomBen Gouaux
Jul 14, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·John Peter ZajicekUNKNOWN MUSEC Research Group
Oct 31, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Vincenzo Di Marzo, Luciano De Petrocellis
Jan 5, 2013·Journal of the American Board of Family Medicine : JABFM·Elin Kondrad, Alfred Reid
May 31, 2013·The New England Journal of Medicine·Jonathan N Adler, James A Colbert
Jan 1, 2012·Pharmaceuticals·Simon Zhornitsky, Stéphane Potvin
Dec 10, 2013·Physical Medicine and Rehabilitation Clinics of North America·Christina Hughes, Ileana M Howard
Jun 5, 2014·The New England Journal of Medicine·Nora D VolkowSusan R B Weiss
Aug 5, 2015·Journal of Neurology·G CogheE Cocco
Aug 15, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Vincenzo Di Marzo, Fabiana Piscitelli
Sep 12, 2015·The Lancet. Psychiatry·Edmund SilinsUNKNOWN Cannabis Cohorts Research Consortium
Oct 18, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Laura FerrèFederica Esposito
Nov 17, 2015·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Robert J TaitSimon Lenton
May 11, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·F PattiUNKNOWN SA.FE. study group
May 22, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Susana Otero-RomeroXavier Montalban

❮ Previous
Next ❯

Citations

Apr 14, 2021·Multiple Sclerosis and Related Disorders·Edgar Carnero ContenttiRicardo Alonso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.